HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV- 1-resistant prostitutes in Nairobi

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1602-1611

  Kaul, Rupert ^a,b   Plummer, Francis A ^a,c   Kimani, Joshua ^a   Dong, Tao ^b   Kiama, Peter ^b   Rostron, Timothy ^b   Njagi, Ephantus ^a   MacDonald, Kelly S ^a,d   Bwayo, Job J ^a   McMichael, Andrew J ^b   Rowland Jones, Sarah L ^b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; PRIORITY JOURNAL; PROSTITUTION; VIRUS TRANSMISSION;

EID: 17344381593     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1602     Document Type: Article

References (40)

1. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7:448.
2. + lymphocytes from ex posed-uninfected individuals: association with low expression of CCR5 and high production of β-chemokines. Virology 244:66.
3. Fowke, K. R., T. Dung, S. L. Rowland-Jones, J. Oyugi, W. J. Rutherford, J. Kimani, P. Krausa, J. Bwayo, J. N. Simonsen, G. M. Shearer, and F. A. Plummer. 1998. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced β-chemokine production. AIDS Res. Hum. Retroviruses 14:1521.
4. 1995. World Health Organization: the current global situation of the HIV/AIDS pandemic. Wkly. Epidemiol. Rec. 70:7.
5. d'Cruz-Grote, D. 1996. Prevention of HIV infection in developing countries. Lancet 348:1071.
6. Beyrer, C., A. W. Artenstein, S. Rugpao, H. Stephens, T. C. VanCott, M. L. Robb, M. Rinkaew, D. L. Birx, C. Khamboonruang, P. A. Zimmerman, et al. 1999. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand: Chiang Mai HEPS Working Group. J. Infect. Dis. 179:59.
7. Kaul, R., D. Trabattoni, J. J. Bwayo, D. Arienti, A. Zagliani, F. M. Mwangi, C. Kariuki, E. N. Ngugi, K. S. MacDonald, T. B. Ball, et a. 1999. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 13:23.
8. Mazzoli, S., D. Trabattoni, S. Lo Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, et al. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1250.
9. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudemun, J. A. Zack, P. Gupta, H. N. Ho, P. G. Nishimian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012.
10. Goh, W. C., J. Markee, R. E. Akridge, M. Meldorf, L. Musey, T. Karchmer, M. Krone, A. Collier, L. Corey, M. Emerman, and M. J. McElrath. 1999. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J. Infect. Dis. 179:548.
11. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhcndler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patienls. J. Clin. Invest. 93:1293.
12. Pinto, L. A., J. Sullivan, J. A. Berzofsky, M. Clerici, H. A. Kessler, A. L. Landay, and G. M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867.
13. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860.
14. Rowland-Jones, S., J. Sutlon, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, et al. 1995. HIV-specinc cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
15. Rowland-Jones, S. L., T. Dong, K. R. Fowke, J. Kimani, P. Krausa, H. Newell, T. Blanchard, K. Ariyoshi, J. Oyugi, E. Ngugi, et al. 1998. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102:1758.
16. Kaul, R., K. Fowke, E. Njagi, J. Rutherford, K. S. MacDonald, I, Onyango, J. J. Bwayo, and F. A. Plummer. 1998. HIV-1 specific cytotoxic T-lymphocyte responses in uninfected Kenyan prostitutes: behavioural and immunologic correlates (Abstr. 600/31123). In Twelfth International Conference on AIDS. vol. 1. International AIDS Society, Geneva, Switzerland, p. 519.
17. Zhang, C., Y. Cui, S. Houston, and L. J. Chang. 1996. Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals, Proc. Natl. Acad. Sci. USA 93:14720.
18. Belyakov, I. M., J. D. Ahlers, B. Y. Brandwein, P. Earl, B. L. Kelsall, B. Moss, W. Strober, and J. A. Berzofsky. 1998, The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102:2072.
19. Murphy-Corb, M., L. A. Wilson, A. M. Trichel, D. E. Roberts, K. Xu, S. Ohkawa, B. Woodson, R. Bohm, and J. Blanchard. 1999. Selective induction of protective MHC class 1-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J. Immunol. 162:540.
20. Musey, L., Y. Hu, L. Eckert, M. Christensen, T. Karchmer, and M. J. McElrath. 1997. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J. Exp. Med. 185:293.
21. + T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J. Infect. Dis. 178:260.
22. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827.
23. + memory T cells. J. Exp. Med. 186:859.
24. Ngugi, E. N., F. A. Plummer, J. N. Simonsen, D. W. Cameron, M. Bosire, P. Waiyaki, A. R. Ronald, and J. O. Ndinya-Achola. 1988. Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet 2:887.
25. Simonsen, J. N., F. A. Plummer, E. N. Ngugi, C. Black, J. K. Kreiss, M. N. Gakinya, P. Waiyaki, L. J. D'Costa, J. O. Ndinya-Achola, P. Piot, et al. 1990. HIV infection among lower socioeconomic slrata prostitutes in Nairobi. AIDS 4:139.
26. Fowke, K. R., N. J. Nagelkerke, J. Kimani, J. N. Simonsen, A. O. Anzala, J. J. Bwayo, K. S. MacDonald, E. N. Ngugi, and F. A. Plummer. 1996. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347.
27. Plummer, F. A., T. B. Ball, J. Kimani, and K. R. Fowke. 1999. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol. Lett. 66:27.
28. Bunce, M., C. M. O'Neill, M. C. Bamardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Pholotyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigen 46:355.
29. Dawood, M. R., R. Allan, K. Fowke, J. Embree, and G. W. Hammond. 1992. Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction. J. Clin. Microbiol. 30:2279.
30. Bomsel, M., M. Heyman, H. Hocini, S. Lagaye, L. Belec, C. Dupont, and C. Desgranges. 1998. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 9:277.
31. Yeaman, G. R., H. D. White, A. Howell, R. Prabhala, and C. R. Wira. 1998. The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV. AIDS Res. Hum. Retroviruses 14(Suppl. 1):S57.
32. Patlerson, B. K., A. Landay, J. Andersson, C. Brown, H. Behbahani, D. Jiyamapa, Z. Burki, D. Stanislawski, M. A. Czerniewski, and P. Garcia. 1998. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am. J Pathol. 153:481.
33. Olaitan, A., M. A. Johnson, A. MacLean, and L. W. Poulter. 1996. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS 10:759.
34. Broliden, K., J. Hinkula, C. Devito, S. Frankel, R. Kaul, and M. Clerici. 1999. HIV specific IgA: neutralizing responses in mucosal samples from HIV-exposed, seronegative individuals (Abstr. 105). in HIV Vaccine Development: Opportunities and Challenges, Keystone, CO, p. 34.
35. Zhu, T., L. Corey, R. Akridge, Y. Change, F. Feng, J. Kim, C. Alef, A. McElroy, J. Mullins, and J. McElrath. 1999. Evidence for HIV-1 latent infection in exposed seronegative individuals (Abstr. 8). In 6th Conference an Retroviruses and Opportunistic Infections, Chicago.
36. Anzala, O. A., N. J. D. Nagelkerke, J. J. Bwayo, D. Holton, S. Moses, E. N. Ngugi, J. O. Ndinya-Achola, and F. A. Plummer. 1995. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J. Inf. Dis. 171:686.
37. Goulder, P. J., M. Bunce, P. Krausa, K. McIntyre, S. Crowley, B. Morgan, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1996. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 12:1691.
38. Klein, M. R., S. H. van der Burg, E. Hovenkamp, A. M. Holwerda, J. W. Drijfhout, C. J. Melief, and F. Miedema. 1998. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag-and RT-specific cytoloxic T lymphocyte responses. J. Gen. Virol. 79:2191.
39. Skerrett, D., O. Rosina, O. Gudzowaty, L. Isola, E. Scigliano, and S. Fruchtman. 1999. Comparative analysis of HLA-B 8101 by serology, isoelectric focusing, and sequence-based typing. Hum. Immunol. 60:168.
40. Vilches, C., L. Sanz, R. de Pablo, M. E. Moreno, S. Puente, and M. Kreisler. 1996. Molecular characterization of the new alleles HLA-B*8101 and B*4407. Tissue Antigens 47:139.